

A practical guide for ophthalmologists and prescribers to help patients find Natacyn (Natamycin) in stock, with workflow tips and alternative strategies.
You've diagnosed fungal keratitis and prescribed Natacyn (Natamycin 5% ophthalmic suspension). But as any ophthalmologist knows, prescribing Natacyn is only half the battle — your patient still needs to find it.
Because Natacyn is the sole FDA-approved topical ophthalmic antifungal in the U.S. and most retail pharmacies don't stock it, patients frequently return to your office reporting they can't fill their prescription. This delay in treatment can have serious consequences for vision outcomes.
This guide provides a practical, step-by-step approach to help your patients access Natacyn as quickly as possible.
As of early 2026, Natacyn supply from Alcon Laboratories is not in official shortage per the FDA. However, the practical availability picture remains challenging:
For a full breakdown of supply factors, see our clinical briefing: Natacyn Shortage: What Providers Need to Know in 2026.
Understanding the patient's experience helps inform your workflow:
The result: patients return to your office with an unfilled prescription and a worsening infection.
The single most impactful thing you can do is confirm pharmacy availability while the patient is still in your office. Options include:
This proactive step prevents the most common scenario: a patient leaving with a prescription they can't fill.
Many ophthalmology practices stock Natacyn and dispense it directly. If your state permits physician dispensing, this eliminates the pharmacy availability problem entirely.
Benefits of in-office dispensing:
Check your state's pharmacy board regulations for physician dispensing requirements.
Identify 2-3 pharmacies in your area that reliably stock or can rapidly order Natacyn:
Communicate these pharmacy options to patients at the point of prescribing. A printed handout with pharmacy names and phone numbers reduces patient burden significantly.
For insured patients, Natacyn often requires prior authorization. Initiate this process at the time of prescribing rather than waiting for a pharmacy rejection:
Many insurers will expedite authorization for sight-threatening conditions when the request includes appropriate clinical documentation.
If Natacyn cannot be obtained within a clinically acceptable timeframe, be prepared to pivot:
Having standing relationships with compounding pharmacies ensures you can pivot quickly without additional delays.
When Natacyn is not available or clinically suboptimal, consider these compounded alternatives:
All require sterile compounding. For a detailed comparison, direct patients to: Alternatives to Natacyn.
Integrate these steps into your clinical workflow to minimize disruption:
Natacyn access challenges are a known issue in ophthalmology practice. By building proactive systems — verifying availability at the point of care, maintaining specialty pharmacy relationships, and having compounded alternatives ready — you can ensure your patients receive timely antifungal treatment regardless of supply fluctuations.
Key takeaways for providers:
For the latest supply updates, see our 2026 provider briefing on Natacyn availability.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.